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Abstract 
 
There is evidence to suggest that high altitude (HA) exposure leads to a fall in heart rate 
variability (HRV) that is linked to the development of acute mountain sickness (AMS).  The 
effects of sex on changes in HRV at HA and its relationship to AMS are unknown. Methods. 
HRV (5-minute single lead ECG) was measured in 63 healthy adults (41 men and 22 women) 
aged 18-56 years at sea level (SL) and during a HA trek at 3619m, 4600m and 5140m 
respectively. The main effects of altitude (SL, 3619, 4600 and 5140m) and sex (men vs women) 
and their potential interaction were assessed using a Factorial Repeated Measures ANOVA. 
Logistic regression analyses were performed to assess the ability of HRV to predict AMS. 
Results. Men and women were of similar age (31.2 ±9.3 vs 31.7±7.5 years), ethnicity, body and 
mass index.   There was main effect for altitude on heart rate, SDNN (standard deviation [SD] of 
normal-to-normal [NN] intervals), RMSSD (Root mean square of successive differences), NN50 
(number of pairs of successive NNs differing by >50 ms), pNN50 (NN50 / total number of NNs), 
very low frequency (VLF), low frequency (LF), high frequency (HF) and total power (TP). The 
most consistent effect on post hoc analysis was reduction in these HRV measures between 3619 
and 5140m at HA. Heart rate was significantly lower and SDNN, RMSSD, LF, HF and TP were 
higher in men compared with women at HA. There was no interaction between sex and altitude 
for any of the HRV indices measured. HRV was not predictive of AMS development. 
Conclusions. Increasing HA leads to a reduction in HRV. Significant differences between men 
and women emerge at HA. HRV was not predictive of AMS. 
 
Key words: sex, high altitude, Heart rate variability, hypoxia 
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Introduction  
 
The assessment of heart rate variability (HRV) has rapidly evolved from what was 
predominantly a research tool to an increasingly appreciated clinical modality (1). Its most 
widespread translational use at present is in the assessment of psychological stress, physical 
fitness and the prevention of overtraining (1, 26). The improved portability and reduced cost of 
HRV-measurement equipment have also played a significant role in this regard.  HRV 
assessment relies on the detailed assessment of the variations in the time-intervals between 
consecutive heart beats which are subject to continuous autonomic control (26,28). From these 
data, the changes in the beat-beat intervals over time (time-domain analyses) can be more 
robustly quantified from as little as 1-5 minutes of recording (1,27,29). The beat-to-beat data can 
be further examined by frequency domain analysis whereby the generated sinusoidal waveforms 
of these intervals over time, are placed into various frequency components, allowing for a more 
in depth analysis of autonomic balance (26,28). 
 
 An area of recent interest has been in the effects of high altitude (HA) on HRV (6-8, 20). 
HA exposure challenges several physiological systems that are heavily reliant on continuous 
autonomic control and are likely to influence HRV (7,8,21,22). Acute hypoxia and HA leads to 
marked sympathetic activation yet paradoxically there is also evidence of increased competing 
parasympathetic activity which contributes to the reduction in maximal heart rate in proportion 
to the altitude gained (7,8,19,21). Hypobaric hypoxia, cold, exercise, stress and fatigue, which 
are synonymous with HA exposure, are all known individually to influence HRV (8,16).  
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There are data to suggest that acute hypoxia and HA exposure leads to a decline in HRV 
(8,20) with conflicting data on its potential link to HA-related symptoms and acute mountain 
sickness (AMS) (12,13,29). Published studies on HRV at HA have been derived from relatively 
small cohorts, with very little data on the effects of genuine terrestrial, rather than simulated HA 
(6,12,13). Moreover, there has been an under-representation of women, in current datasets, 
despite their obvious physical and potentially important physiological differences compared to 
men. Resting heart rate tends to be higher in women than men, yet their stroke volumes and 
cardiac outputs are lower and these differences are sustained and even enhanced with hypoxia 
(5,14). Resting minute ventilation, which affects HRV, is relatively greater in women under both 
normoxia and hypoxia (23). Time-domain measures of HRV are typically higher in healthy men 
(<50 years) compared with age-matched women (5,14,24). However, the power spectral density 
(PSD) of HRV in females is usually characterized by less total power (TP), greater or similar 
high-frequency (HF) and lower low-frequency (LF) power and LF/HF ratios (14,27,28).  
 
There are some data to suggest that women may be also more vulnerable to both AMS 
development and worsening symptom severity compared with men (9,18,25).  Given the possible 
sexual dimorphism in HRV and AMS incidence/severity coupled with the reported links between 
HRV and AMS an investigation of comparative HRV in men and women and its relationship to 
AMS development is warranted.  
 
In this study, we aimed to investigate, for the first time, the influence of sex on time and 
frequency-domain measures of HRV with increasing terrestrial HA and its potential link to AMS 
development. 
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Methods 
Study design and participants 
Sixty-three healthy British Military servicemen aged >18years were included. They were all 
assessed at near SL (<200m) and again at three further altitudes during progressive HA ascent in 
the Dhaulagiri region of the Himalayas in March/April 2016. Health status was confirmed 
following a detailed baseline questionnaire. For inclusion, all subjects needed to be low altitude 
dwellers and were required to be deemed medically fit for HA exposure by their medical 
practitioners. All participants were required to have successfully completed their mandatory 
military Personal Fitness Assessment 1.5 mile run in accordance with published standards 
(adjusted to age and sex) prior to inclusion. This run was undertaken in sports clothing on a flat 
surface. Subjects with a history of cardiac arrhythmias were excluded. The subjects were studied 
consecutively in groups of 8-14 at sea level and at HA with a two-day stagger between 
successive groups.  All trekking groups followed an identical ascent and exercise recovery 
profile with similar morning wake times. Sea level (SL) baseline assessments were performed in 
the UK approximately six weeks prior to each departure.  
 
High Altitude Ascent and descent profile 
The subjects flew from the UK to Kathmandu (1400m) where they underwent two days of local 
acclimatisation (Days 1-3). Thereafter, they travelled by road over two days to 1030m 
(Darbang). From there they commenced trekking on foot over the ensuing 11 days to an altitude 
of 5140m (with an overpass of 5360m) before commencing their decent on foot to Marpha 
(2719m) and then by road back to Kathmandu. Research assessments were performed at SL and 
at static research camps at 3619m, 4600m and 5140m during HA ascent.  
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Physiological Assessments and Heart Rate Variability 
Oxygen saturations (SpO2) were measured using a Nonin Onyx (Nonin Medical Inc, Plymouth, 
Minnesota) pulse oximeter with sampling over approximately 15 seconds. HA-related symptoms 
were recorded using the Lake Louis Scoring (LLS) system. AMS was defined as a LLS of >3 in 
the presence of headache (11,15).  HRV assessments were undertaken using dedicated battery-
operated portable HRV devices which records a single lead ECG at a sampling rate of 
250/second (CheckMyHeart Plus™ Daily Care Biomedical, Taiwan) as previously described (5). 
The first of the two surface ECG electrodes were placed at the right sternal edge at one finger 
breathe below the suprasternal notch and the second over the left 5
th
 intercostal space at the mid 
clavicular line (i.e. cardiac apex).  Measurements were taken on fully rested subjects over a five-
minute period in the early morning post-micturition and prior to breakfast or caffeine (6). All 
subjects were studied seated in a warm building at sea level and wearing warm clothing and in a 
tent at HA and were advised not to talk during HRV assessment. All stored recordings were 
exported via USB hook up for offline data analysis (CheckMyHeart Plus™ R30 V4, Daily Care 
Biomedical, Taiwan). 
 
The R waves of the stored ECG were used as the fucidal point to determine the beat to beat 
interval with full ECG disclosure. Non-normal-to-normal-(NN) intervals and ectopic beats were 
identified using customised software non-linear algorithms and were highlighted by colour 
coding within the HRV software to ease their identification. All ECG data was inspected in six 
second windows for further identification and manual editing of potential non NN intervals if 
necessary. All confirmed non NN intervals due to ectopy were excluded.   The average five-
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minute heart rate, and the SDNN, RMSSD, NN50 and pNN50 time domain measures, as 
previously described, were recorded (26,28). The SDNN refers to the standard deviation of the 
NN intervals from the acquired ECG. The RMSSD (Root mean square of successive differences) 
is the square root of the mean of the squares of the successive differences between adjacent NN 
intervals. The NN50 describes the number of pairs of successive NNs that differ by >50 ms and 
the pNN50 refers to the proportion of NN50 divided by total number of NN intervals. 
Frequency-domain analysis was performed using the non-detrend method of fast Fourier 
transformation (FFT) with full graphical display of the power spectral data. Key frequency band 
data collected were the HF power (0.15-0.40 Hz), LF power (LF; 0.04-0.15 Hz), very low 
frequency power (VLF; 0.01-0.04 Hz), TP and the LF: HF ratio as previously defined (21,23). 
Normalized HRV values of LF (LFnu) and HF (HFnu) were calculated as a percentage of the 
total spectral power minus the VLF respectively (28).  
 
Ethics 
All participation was voluntary and all subjects underwent detailed written informed consent.  
This study was approved by the Ministry of Defence Research and Medical Ethics Committee 
(MODREC) and was conducted according to the standards of the Declaration of Helsinki.  
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Statistical analysis  
Data were analysed using GraphPad InStat version 3.05 and SPSS
®
 statistics version 22 
with all graphical figures presented using GraphPad Prism version 4.00 for Windows (GraphPad 
Software, San Diego, CA, USA). Sample size calculations were performed using a proprietary 
determined sample size calculator using (GraphPad StatMate version 2.00 for Windows). Data 
inspection and the Kolmogorov-Smirnov test was undertaken to assess normality of all 
continuous data, which were presented as mean ± standard deviations and as the standard error of 
the mean (SEM) for figures. Categorical variables were compared using a Chi-Squared test. 
Comparison of unpaired data was performed using an independent t test and a Mann-Whitney 
test for parametric and non-parametric data respectively.  Correlations were performed using 
Pearson and Spearman rank correlation (±95% confidence interval, CI) for parametric and non-
parametric data respectively.  A Factorial Repeated Measures ANOVA with Bonferroni 
correction (to minimise type I error) was performed to assess the main effect of sex (men vs 
women) over the four altitude time points (SL, 3619m, 4600m and 5140) and any interaction of 
altitude x sex on HRV scores. Binary logistic regression analyses (enter) were undertaken to 
assess potential continuous HRV and other univariate predictors of AMS development (yes or 
no) and its coefficient (B). We also undertook an additional exploratory analysis of the 
categorical HRV measures of RMSSD <30ms, LF:HF >1.3 and LFnu <20% that have been 
previously reported to be associated with AMS  (12,13) .  Non-parametric data was log (Ln) 
transformed and normality confirmed for the ANOVA and logistic regression analyses. A two 
tailed P value <0.05 was considered statistically significant for all comparisons.  
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Sample size calculations  
In a recent pilot study in Dhaulagiri, which included 12 subjects, we observed a non-significant 
but 11% (-7.9 ms) fall in the RMSSD time domain measure of HRV from baseline to 3600m, 
using identical HRV (CheckMyHeart Plus™) devices (6). Hence, by studying an even greater 
altitude of >5000m we calculated that a sample size of >18 subjects in each group (men vs 
women) would have >80% power to detect a significant change in the RMSSD at HA at a 
significance level (alpha) of 0.05 (two-tailed). In another recent study Saleem et al documented 
that the SDNN was significantly higher in 27 healthy men versus 18 healthy women (24). We 
estimated that a sample size of at least 18 women and >30 men studied across four differing 
altitudes would have sufficient power to detect a significant sex difference in HRV including 
SDNN.  
 
Results 
HRV data were available on 62 subjects at SL and at 3619 m and on 58 subjects at 4600m and 
5140m respectively. The men (31.2±9.3 years) and women (31.7±7.5 years) were well matched 
for age, ethnicity, smoking history and body mass index (table 1). As expected, the men were on 
average taller and heavier with higher systolic blood pressures at baseline, with faster completion 
times for their mandatory annual 1.5 mile running fitness test (P<0.0001) (table 1).  
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 HA exposure led to a significant fall in SpO2 and an increase LLS among both men and 
women, compared to baseline with no effect for subject sex (table 2). Heart rate (five-minute 
average) increased at HA in both sexes, with women having consistently higher rates than men 
both at SL and at HA (table 2 and 4). 
 
 There was a significant main effect for altitude on all time-domain measures of HRV. On 
post-hoc analysis this represented a significant reduction in time-domain measures of HRV most 
consistently between 3619m to 5140m (table 2 and 4; figure 1). There was a significant main 
effect for altitude on LF, HF and TP. This difference was again most marked on post-hoc 
analyses between 3619m and 5140m where significant reductions in LF, HF and TP were 
observed (table 3 and 4; Figures 2).  
 
Time domain measures of HRV were non-significantly higher in men at SL and 
significant differences emerged at HA, where all measures were notably higher in men (table 2 
and 4; figure 1).  There was also a main effect for sex among the frequency domain measures of 
TP, LF and HF power which were all significantly higher in men at HA (table 3 and 4, figure 2). 
There were no interactions between sex (men vs women) x altitude (SL, 3619m, 4600m and 
5140m) on any measures of HRV (table 4) or heart rate.  
 
SpO2 inversely correlated with LLS (r=-0.38; 95% CI -0.50 to -0.24; p<0.0001) and 
positively with RMSSD (r=0.16; p=0.02), SDNN (r=0.18; 0.05 to 0.30: p=0.007), VLF (r=0.17; 
0.04 to 0.30; p=0.01), LF (r=0.16; 0.03 to 0.29; p=0.2) and TP (r=0.17; 0.03 to 0.29; P=0.02).  
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The prevalence of AMS increased at HA from 15.2% at 3619m to 27.3%  at 4600m and 
32.5% at 5140m (p=0.004). Reducing SpO2 (B -0.13; P<0.0001) and increasing altitude (B 0.80; 
P <0.0001) and mean heart rate (B 0.03; P=0.04) were the only univariate predictors of AMS. 
None of the continuous measured HRV parameters or the categorical variable of subject sex 
(men vs women) were predictive of AMS. RMSSD <30ms, LF:HF >1.3 and LFnu <20% were 
not predictive of or associated with AMS.  
 
Discussion 
This is the largest study to assess the effects of HA on HRV, and to the author’s knowledge the 
first study to investigate the influence of sex on HRV at terrestrial HA. In this study HRV was 
influenced by HA. Minor sex-related differences in HRV that were observed at SL were 
sustained at genuine terrestrial HA. A link between HRV and symptoms of AMS were not found.    
 
 We observed a significant fall in resting SpO2 and an increase in LLS with 
increasing HA. There was also a significant main effect for altitude on heart rate (which 
increased) and all the evaluated time-domain measured of HRV. The most consistent change was 
between 3619 and 5140m, and hence at higher altitude, where there was a significant fall in 
SDNN, RMSSD, NN50, PNN50, LF and HF power.  These findings are in keeping with 
published data that has shown a fall in time-domain measures of HRV at HA (12,13,29). These 
changes are in part explained by a number of factors linked to the HA environment. These 
include reducing sleep quality, extremes of cold and heat, physical exhaustion and increasing 
anxiety which are all known to adversely affect and reduce time domain measures of HRV 
(13,19,30).  
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We also observed a significant main effect for sex on heart rate and time domain 
measures of HRV at HA, with men having consistently higher scores and greater variability. This 
is a novel finding. Whilst published data has shown a consistent trend to higher time domain 
measures of HRV in young adult men versus women at SL (3,14,24). This is the first 
comparative study at HA. The trend to higher time domain HRV measures at SL became 
significant at HA. There was no interaction of altitude on sex on the time domain HRV 
parameters. This finding can be partly explained by the sex differences in heart rate which was 
consistently lower in the men. Heart rate is well known inversely correlate with all main time 
domain measures of HRV (28).  
 
We also observed a significant effect of altitude (SL, 3619m, 4600m and 5140m) on TP, 
VLF, LF and HF power. The most consistent finding, on post-hoc analyses was a reduction in 
these parameters at the highest altitude of 5140m vs sea level and 3619m. HA exposure was also 
associated with a significant main effect of sex with greater TP, LF and HF power among the 
men. Results from a very recently published meta-analysis of comparative HRV measures 
among men and women at SL, that included more than 60,000 participants, demonstrated that 
when compared to that seen in women, PSD in men is generally characterised by lower HF 
power and greater LF, TP and LF/HF ratios (14). This is thought to reflect their higher resting 
sympatho-vagal tone (hence greater LF and LF/HF ratios) compared with women. Our LF data 
supports this previous data. However, contrary to the published data we found that HF power 
was actually higher with variable effects on LF/HF power among the men.  There are several 
potential factors that might explain these results. It is known that LF, HF power and their relative 
ratios (LF/HF) can be markedly influenced by a number of factors which include age, respiratory 
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rate, recording length and heart rate (3,14,23,26,28).  Whilst the ages were similar between the 
men and the women the greater heart rates in women would have led to the analysis of a higher 
number of beat-to-beat intervals, despite an identical recording period,  which could be an 
important  confounder. Secondly, whilst increasing heart rate and minute ventilation are HA are 
thought to relate to enhanced sympathetic activation there is also evidence of elevated 
parasympathetic neural activity (4,7,21,22). This increase in competing vagal activation at HA is 
thought to contribute to the reduction in maximal heart rate at HA (7). LF power and the LF/HF 
ratio have been traditionally thought to represent sympathetic activation and net sympatho-vagal 
balance respectively with RMSSD and HF power reflecting parasympathetic nerve activity (28). 
However, there is evolving evidence to show that these arbitrary assumptions about the discrete 
autonomic effects these HRV measures, may be overly simplistic (2).   
 
Our identified sex-related dissimilarities in the time and frequency domain HRV 
measures at HA could also relate to differences in fitness levels. Indeed, the men in our study 
had higher time domain measures of HRV and lower 1.5 mile run times. Our findings could also 
relate dissimilarities in acclimatisation in men vs women. Acclimatisation encompasses the 
cumulative effects of multiple factors such as hydration, ventilation and enuresis that are known 
to influence autonomic balance and HRV (10). HRV, and in particular frequency domain 
analysis can be significantly affected by breathing pattern and ventilation, which are markedly 
affected HA where hypoxia driven hyperventilation predominates (14,17,18). In our study paced 
breathing during HRV assessments were not performed, but the participants were encouraged to 
relax and breathe normally.  The majority of published studies on HRV at HA have utilised 
spontaneous non-paced breathing, hence were keen to utilise a comparative methodology 
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(7,9,10,24).  Our participants were assessed at far higher altitudes and under greater hypoxia than 
most of the previous HA HRV studies to date, hence the potential challenge to paced breathing 
was likely to have been greater. We anticipated that at 4600 and 5140m controlled breathing 
under significant hypoxia and a high ventilatory drive might paradoxically increase subject 
anxiety and perceived breathlessness.  By enforcing a similar paced breathing protocol in both 
men and women we risked neutralising genuine sex-related differences in HRV related to well-
reported dissimilarities in ventilation between men and women at HA (2,19). Unfortunately, we 
did not measure comparative respiratory rate and ventilation among the men vs women. This is 
an obvious limitation as sex-related differences in their spontaneous breathing it could have 
provided further insight into the observed differences in HRV identified.  
 
 We did not observe a link between AMS and HRV in this current study. There is limited 
evidence linking changes in HRV to AMS, raising the prospect of using HRV as a non-invasive 
predictor of AMS development (9,10). In a previous study Karinen et al investigated 36 different 
healthy climbers ascending from 2400 m to 6300 m altitudes during five differing expeditions 
and noted that a lower RMSSD and HF at 2400m was a marker of AMS at 3000 to 4300m (10). 
However, contrary to our study, the speed of ascent varied between their five studied groups. 
Furthermore, they measured HRV over two rather than five minutes. In another study, of similar 
size (n=32), Hang et al noted that a HF% <20% (nu) or LF/HF ratio >1.3 at lower altitudes was 
predictive of AMS at 3400m (9). These HRV parameters failed to be either associated or predict 
AMS in or study. Willie et al in a prolonged normobaric hypoxia study and our group in another 
recent study (ithlete RMSSD-derived HRV score), failed to identify a clear link between AMS 
and HRV supporting our data (16, 23).   
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The potential reasons for the contradictory findings in HRV to predict AMS may relate to 
differences in study design, HA environment, ascent/hypoxic profile, HRV recording time as 
well as the actual HRV parameters measures.  Even the definitions of AMS that were used 
differed between these studies. For example, Karinen et al defined AMS as a LLS of >3 in their 
study whereas in the study by Willie they a LLS ≥4 was used to define AMS (10,24). In our 
study we used the Lake Louise Consensus definition (1992) for AMS, which is refers to LLS 
score of >3 in the presence of headache (4,8,12). It is well known that AMS is a highly complex 
and heterogeneous condition. Its causative mechanisms include changes in cerebral arterial blood 
flow and increased vascular permeability within the blood brain barrier, both of which may be 
influenced by local autonomic control (18). Whilst HRV reflects overall cardiac autonomic 
control it is relatively non-specific and is not indicative of local autonomic balance (2,18).  
 
  This study has several additional imitations that should be mentioned. The subjects were 
studied in consecutive groups of 8-14 two days apart and not all together in one batch. This was 
because of the large sample size for this type of remote field study and the need to undertake at 
HRV in the early morning pre-breakfast and caffeine.  We measured five minute HRV which 
may be more vulnerable to short-term sex and situational bias than that obtained from longer 
recordings (22). However, five minute HRV measurement is well-validated and endorsed by the 
current HRV Task Force Guidelines and is more potentially applicable to clinical practice than 
that of longer recordings (22). We included a larger proportion of men than women and cannot 
exclude the possibility of sample bias, despite their similarities in age, ethnicity, smoking history 
and body mass index.   
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In conclusion our findings indicate that increasing HA was associated with a reduction in 
HRV which was most notable at 4600m and above.  There were significant sex related 
differences in HRV between men and women which were sustained at HA. There was no 
interaction between sex and altitude on any of the HRV parameters measured. These sex-related 
differences may reflect dissimilarities in their autonomic balance and acclimatisation to HA. 
HRV was not predictive of AMS.    
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Legends for Figures 
 
Figure 1 Comparative Changes in the RMSSD (mean ± SEM) among men and women at sea 
level and increasing high altitude. Post-test differences on repeated measures ANOVA: * versus 
sea level, ‡ 3619 vs 5140m, †3619 vs 4600m. 
 
Figure 2 Comparative Changes in Low frequency (LnLF) Power (mean ± SEM) among men and 
women at sea level and increasing high altitude. Post-test differences on repeated measures 
ANOVA: * versus sea level, ‡ 3619 vs 5140m. 
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Figure 2 
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Table 1: Baseline Demographics  
   Demographic Overall Men Women P value* 
Number (%) 63 (100%) 41 (65%) 22 (35%)  
Age, years (range) 31.41 ± 8.7 (18-56) 31.2 ± 9.3 31.7 ± 7.5 0.83 
Height (cm) 173.4 ± 9.7 177.1±9.3 166.5±5.8 <0.0001 
Weight (kg) 72.5 ± 13.0 77.4±12.1 63.2 ± 9.3 <0.0001 
Body mass index, kg/m
2
 24.0 ± 2.8 24.2 ± 3.0 23.5± 2.6 0.36 
Systolic blood pressure 
(mmHg)  
132.1 ± 15.6 136.9 ± 15.1 123.7 ± 12.7 <0.0001 
Diastolic blood pressure 
(mmHg) 
80.5 ± 14.6 80.8 ± 12.4 78.7 ± 10.7 0.53 
Basic fitness test time 
(minutes)  
9.9  ± 1.3 9.5 ± 1.1 10.8 ± 1.2 <0.0001 
Hormonal contraception  
(pill / implant) 
5 (7.9%) 0 5 (22.7%) <0.0001 
Ethnicity, % 
- Caucasian  
- Non Caucasian  
 
56 (88.9%) 
7 (11.1%) 
 
35 (85.4%) 
6 (14.6%) 
 
21 (95.5%) 
1 (5.5%) 
 
 
0.40 
Smoking status (%) 
- Never  
- Current 
- Ex 
 
51 (81.0%) 
4 (6.3%) 
8 (12.7%) 
 
33 (80.4%) 
4 (9.8%) 
4 (9.8%) 
 
18 (81.8%) 
0 (0%) 
4 (18.2%) 
 
 
 
0.23 
*p value refers to results of comparison of men vs women only  
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Table 2 Changes in SpO2 and time domain measures of Heart rate Variability at sea level to 
increasing high altitude 
 Sea level 3619m 4600m 5140m Post-test Paired 
differences for effects 
of altitude 
SpO2 (%) 
-Men   
-Women   
 
97.7 ±1.3 
97.9 ± 1.3 
 
93.1 ± 3.2 
90.9 ± 4.5 
 
83.5 ± 6.0 
80.4 ± 8.5 
 
81.3 ± 5.3 
78.6 ± 5.4 
 
abcef 
 
Lake Louis Scores 
-Men   
-Women   
 
0.4 ± 0.6 
0.5 ±  0.9 
 
1.0 ± 2.1 
1.5 ± 2.4 
 
1.9 ±2.2  
2.3 ± 1.2 
 
1.5 ± 1.5 
1.3 ±1.4 
 
abc 
Mean heart rate/minute 
-Men   
-Women   
 
57.6 ± 9.0 
60.8 ± 9.7 
 
63.6 ± 12.0 
69.5 ± 9.4 
 
72.7 ± 15.2 
79.5 ± 12.8 
 
74.5 ± 15.7 
81.1 ± 11.8 
 
abcde 
SDNN (ms) 
-Men   
-Women   
 
78.1 ± 25.2 
76.0 ± 28.3 
 
94.8 ± 55.9 
74.6 ± 29.1 
 
85.0 ± 451.7 
52.5 ± 20.8 
 
72.1 ± 49.2 
51.4 ± 28.0 
 
abcde 
RMSDD (ms) 
-Men   
-Women 
 
67.0 ± 31.6 
59.6 ± 32.2 
 
93.2 ± 72.9 
60.8 ± 30.2 
 
76.2 ± 56.4 
37.3 ± 19.5 
 
62.2 ± 54.6 
41.5 ± 32.6 
 
cde 
NN50 
-Men   
-Women   
 
104.8 ± 38.6 
96.3 ± 54.6 
 
113.0 ± 76.0 
104.8 ±59.1 
 
105.5 ± 75.2 
54.4 ± 51.4 
 
81.9 ± 64.0 
60.0 ± 65.3 
 
ce 
pNN50 (%) 
-Men   
-Women   
 
37.8 ± 19.8 
32.8 ± 19.8 
 
39.6 ± 27.8 
32.2 ± 18.8 
 
34.1 ± 25.6 
14.7 ± 14.3 
 
26.5 ±22.2 
16.4 ± 18.8 
 
cde 
Results of post hoc paired differences with time (altitude) for both men and women: a, sea level vs 3619m; b sea 
level vs  4600m; c sea level vs 5140m; d, 3619m vs 4600m; e, 3619 vs 5140m; f 4600m vs 5140m 
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Table 3 Changes Frequency domain measures of Heart rate Variability at sea level to increasing 
high altitude 
 Sea level 3619m 4600m 5140m Post-test Paired 
differences for 
effects of altitude 
Total power (ms
2
) 
-Men   
-Women   
 
7.87 ± 0.7 
7.75 ± 0.7 
 
7.95 ± 1.4 
7.73 ± 0.8 
 
7.86 ± 1.6 
7.05 ± 0.7 
 
7.34 ± 1.5 
7.0 ± 1.0 
 
cef 
VLF (ms
2
) 
-Men   
-Women   
 
6.06 ± 0.7 
6.16 ± 0.8 
 
6.11 ± 1.2 
5.92 ± 0.9 
 
6.00 ± 1.3 
5.44 ± 0.7 
 
5.62 ± 1.3 
5.28 ± 1.1 
 
ce 
LnLF (ms
2
) 
-Men   
-Women   
 
6.80 ± 0.8 
6.44 ± 0.7 
 
6.61 ± 1.4 
6.67 ± 1.0 
 
6.62 ± 1.7 
5.89 ± 0.9 
 
6.19 ± 1.4 
5.76 ± 1.0 
 
ce 
LnHF (ms
2
) 
-Men   
-Women   
 
6.55 ± 0.8 
6.23 ± 1.0 
 
6.87 ± 1.7 
6.36 ± 0.9 
 
6.50 ± 2.1 
5.47 ± 1.0 
 
6.09 ± 1.8 
5.43 ± 1.3 
 
e 
LF%, nu 
-Men   
-Women   
 
55.4 ± 15.9 
44.5 ± 18.8 
 
44.7 ± 18.0 
56.8 ± 15.6 
 
52.7 ± 17.9 
58.8 ± 16.4 
 
52.0 ± 18.8 
56.8 ± 20.6 
 
NS 
HF%, nu 
-Men   
-Women   
 
44.6 ± 15.9 
45.7 ± 18.4 
 
55.4 ± 18.0 
43.2 ± 15.6 
 
47.3 ± 17.6 
41.2 ± 16.4 
 
48.0 ± 18.8 
43.2 ± 20.6 
 
NS 
LF / HF 
-Men   
-Women   
 
1.7 ± 1.3 
1.4 ± 1.1 
 
1.0  ± 0.80 
1.6  ± 1.0 
 
1.6 ± 1.5 
2.1 ± 1.8 
 
1.6 ± 1.5 
2.2 ± 2.2 
 
NS 
NS, Non-significant; Results of post hoc paired differences with time for men and women combined: a, sea level vs 
3619m; b sea level vs  4600m; c sea level vs 5140m; d, 3619m vs 4600m; e, 3619 vs 5140m; f 4600m vs 5140m  
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Table 4 Results of Two-way Repeated Measures ANOVA comparing the main effects of altitude 
(SL, 3619m, 4600m and 5140m) and sex (men vs women) on measures of heart rate variability  
 Time (altitude) Sex  Interaction 
 F P value F P value F P Value 
SpO2 165.20 <0.001
abcef
 0.49 0.48 0.21 0.89 
Lake Louis Scores 4.30 0.008
abc 
0.37 0.55 0.63 0.60 
Mean heart rate 47.3 <0.001
abcde
 4.10 0.04 0.43 0.73 
SDNN   40.6 <0.001
abcde
 4.00 0.04
 
 1.14 0.26 
RMSDD  8.10 <0.001
cde
 4.40 0.04 0.94 0.43 
NN50  8.20 <0.001
ce
 3.20 0.08 0.82 0.47 
PNN50 10.7 <0.001
cde
 3.50 0.06 0.94 0.41 
SD1 / SD2  1.89 0.13 4.90 0.03 0.34 0.80 
Total power 8.40 <0.001
cef
 4.20 0.04 1.87 0.14 
VLF 7.10 <0.001
ce
 2.00 0.17 1.76 0.16 
LF 7.10 <0.001
ce
 3.80 0.048 1.70 0.17 
HF 5.80 0.001
e
 5.80 0.02 1.26 0.29 
LFnu 0.39 0.76 3.10 0.09 1.70 0.17 
HFnu 0.39 0.76 3.10 0.09 1.70 0.17 
LF / HF  0.50 0.70 1.60 0.20 3.50 0.07 
SpO2, oxygen saturations;  Results of post hoc paired differences with time (altitude) a, sea level vs 
3619m; b sea level vs  4600m; c sea level vs 5140m; d, 3619m vs 4600m; e, 3619 vs 5140m; f 4600m vs 
5140m AC
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PT
ED
